Vivo Surgical

Our CEO, Dr. Kevin Koh, PhD, was recently interviewed by The Straits Times to commemorate the 30th Anniversary of the Suzhou Industrial Park (SIP) - a major milestone for one of Asia’s leading innovation hubs established as a joint venture between the governments of Singapore and China. With several top medtech companies already having a well-established presence in the SIP (e.g. Johnson & Johnson MedTech, Boston Scientific, Olympus APAC, Philips, Stryker, Baxter International Inc., etc), Vivo Surgical is proud to be amongst the ranks of these industry leaders and contributing to the Park’s vibrant medical technology landscape. We would like to thank our esteemed partners, China-Singapore Suzhou Industrial Park Development Group Co., Ltd (CSSD) and the A*STAR - Agency for Science, Technology and Research's A*STAR Partners' Centre, for helping with our “soft-landing” in the SIP and look forward to deepening our partnership in the years ahead! #vivosurgical #suzhouindustrialpark #sip #industrial #marketaccess #china #medtech #medicaltechnology #Innovation #nextgen #surgicalrobotics #surgicalinnovation #endoscope #endoscopy #colonoscopy #clinical #clinicaltrials #surgery #eres #flexibleendoscope #robotics

Vivo Surgical was in attendance at the Asia Pacific Medical Technology Association (APACMed) MedTech Forum this past week as part of the Johnson & Johnson Innovation - JLABS Singapore pavilion. We would like to thank our industry partners and friends who came by for a chat - it was great catching up with everyone! This year, our Founder & CEO, Kevin Koh, PhD and Head of Technology, Richard Lieu, were also invited to represent the startup product owner community for strategic discussions centred around manufacturing at: 1. A closed-door luncheon and roundtable discussion organised by Enterprise Singapore, Singapore Economic Development Board (EDB) and MedTech Catapult with some of Singapore’s top MedTech contract (and design) manufacturers, where we joined Alan Goh from NDR Medical Technology Pte Ltd and Jane Wang from Roceso Technologies to share our thoughts on how established medtech manufacturers could further support early stage startup companies through value-added D&D services and potential equity investments; and 2. A networking/dialogue session entitled "Building a MedTech Manufacturing Ecosystem for Scalabilty" as part the MedTech Forum’s main program, where we shared the stage with John Eng from Singapore Economic Development Board (EDB), Enci Mary Kan from MedTech Catapult, Meng Koh from Flex Health Solutions and John Collings from Stryker to discuss the MedTech manufacturing ecosystem in Singapore and the region. To cap off the eventful week, we attended MedTech Innovator Asia Pacific’s networking reception, courtesy of Paul Grand and Fredrik Nyberg, where we got to meet the winners from the 2024 cohort as well as fellow winners from the previous years. Heartiest congratulations to John Collings, Harjit Gill, Gabriel SIM and all at Asia Pacific Medical Technology Association (APACMed) on yet another buzzing MedTech Forum! (Photos are courtesy of the various aforementioned organisations in the post) Aijuan Iris Zhang Melanie Chan Celine Ling #APACMTF #vivosurgical #medtech #manufacturing #singapore

Hear from Vivo Surgical's Head of Technology, Richard Lieu, as he speaks at the Networking Dialogue session entitled "Building a MedTech Manufacturing Ecosystem for Scalabilty" held at this year's MedTech Forum (https://medtechforum.asia) at the Suntec Singapore Convention & Exhibition Centre on 6 Sep 2024. We are thankful to the event sponsors, Enterprise Singapore, Singapore Economic Development Board (EDB) and MedTech Catapult, and look forward to what promises to be a lively discussion alongside our industry friends from Stryker and Flex Health Solutions. The registration link can be found in the flyer below. See you there! #APACMTF #vivosurgical

◀ Appointment of New Advisory Board Member - Mr Yasushi Takigawa ▶ Vivo Surgical is delighted to welcome Mr Yasushi Takigawa to our company's International Business Advisory Board. Yasushi brings over 30 years of distinguished experience in the healthcare industry, complemented by a robust background in investment banking and corporate finance. His expertise is widely recognized, with significant achievements during his tenure at Boston Scientific, where he held multiple leadership roles. As Vice President of Endoscopy and Business Development for Boston Scientific Asia Pacific, Yasushi was instrumental in establishing and expanding the business development team, leading over 30 successful transactions, and driving business transformation strategies across APAC. His leadership in the Endoscopy Division at Boston Scientific Japan was marked by a remarkable business growth, making it the largest business unit within the company. In addition to his time at Boston Scientific, Yasushi has played a crucial role in founding and scaling healthcare ventures, securing product licenses, and building strong partnerships across the US, Japan, and APAC regions. His bilingual proficiency in Japanese and English, along with a deep understanding of both Western and Eastern business practices, makes him an invaluable addition to our team. We are excited to leverage Yasushi's extensive experience and insights as we continue to push the boundaries of innovation in endoscopy and robotics. Please join us in warmly welcoming him! #vivosurgical #businessadvisoryboard #newappointment #strategy #strategic #businessdevelopment #endoscopy #endoscopicsurgery #surgery #surgical #robotics #ESD #endoscopicsubmucosaldissection #medicaltechnology #medtech (Photo credit: Delawave, Inc)

As we celebrate IP Week @ SG 2024 in Singapore this week, here's a throwback to Vivo Surgical's introductory video at the World Intellectual Property Organization – WIPO Global Awards 2024 last month, as well as the award acceptance speech by our CEO, Kevin Koh, PhD. The WIPO Global Awards 2024 was held on 17 July 2024 at the WIPO Headquarters in Geneva, Switzerland, during the 65th General Assembly of Member States, where Vivo Surgical was honoured alongside 8 other winners chosen from over 660 companies worldwide. Video Capture from WIPO Webcast Website: https://lnkd.in/gzxKHHsW (Copyright: WIPO / Video: Emmanuel Berrod) WIPO Offical Press Release: https://lnkd.in/dBN3ADaf Vivo Surgical Official Press Release: https://lnkd.in/gDG6tC_h #ipweek #ipos #ipossociety #iposinternational #wipo #wipoglobalawards #intellectualproperty #intangibleassets #vivosurgical #medtech #medicaltechnology #robotics #surgicalrobotics #endoscopicrobot #endoscopy #klaro #enlyt #eres

Many thanks for the shoutout, @World Intellectual Property Organization! Truly an honour for Vivo Surgical to be selected as a winner of the WIPO Global Awards for 2024. This award highlights our spirit of innovation, and recognises the folks working hard behind the scenes to deliver healthcare impact where it's most needed. Access the official WIPO press release here: https://lnkd.in/gQhYg_B9 #WIPO #WIPOGlobalAwards #VivoSurgical #Singapore #MedTech #Healthcare #Invention #Innovation #IntellectualProperty #IntangibleAssets

Vivo Surgical was recently announced as a winner of the prestigious World Intellectual Property Organization – WIPO Global Awards for 2024! Our company’s Founder & CEO, Dr Kevin Koh, PhD, received the winners’ trophy from WIPO Director General Daren Tang at a glittering awards ceremony held during the WIPO General Assembly on 12 July 2024 in Geneva, Switzerland. Being selected as one of the final winners from over 660 companies across 107 countries is a remarkable honour, and we would like to sincerely thank the WIPO and all esteemed members of the jury for this distinguished prize. Additionally, we are proud to be addressing several of the United Nations’ Sustainable Development Goals (SDGs) as mentioned during our Awards application, and are grateful to be recognised by the WIPO for driving impact on the following fronts: · Good Health & Well-Being We develop medical devices to enhance the safety and efficiency of clinicians' tasks through innovative science and technology. Our affordable devices, like the ERES™ endoscopic robot, significantly enhances any existing endoscope on the market, democratizing advanced endoscopic robotic technologies for better health outcomes in both developed and developing economies. · Industry, Innovation & Infrastructure As a leading surgical technology company in Southeast Asia, we are driving surgical device innovation in the region, showcasing ASEAN’s capabilities to produce cutting-edge medical technologies. In Singapore, we are now the sole company advancing endoscopic robotic technology, with the aim of cultivating the next generation of robotic engineers and innovators in the Southeast Asian region and beyond. · Reduced Inequalities We shall be addressing the high prevalence of nose cancer in South China and Southeast Asia, especially in rural areas lacking access to expensive imaging equipment. Our ENLYT® portable endoscope enables primary care clinics to more effectively screen for nose cancer, fostering a cultural shift in diagnosis and treatment in emerging economies. Access the official WIPO press release here: https://lnkd.in/gQhYg_B9 For more information about Vivo Surgical and the WIPO Global Awards, please email us at media@vivo-surgical.com. #wipo #wipoglobalawards #intellectualproperty #intangibleassets #vivosurgical #medtech #medicaltechnology #robotics #surgicalrobotics #endoscopicrobot #endoscopy #klaro #enlyt #eres

Thanks very much Enterprise Singapore / EnterpriseSG - North America for the kind mention, as well as your partnership and friendship since our earliest days!

We are gearing up for our first overseas roadshow with the ERES™ endoscopic robot now packed and on its way! It will be an exciting week with back-to-back demo sessions and meetings, and we look forward eagerly to hosting our clinical partners, investors and friends real soon. Kevin Koh, PhD Richard Lieu Aijuan Iris Zhang Justin Lau #vivosurgical #eres #endoscopicrobot #investor #investment #fundraising #roadshow #clinical #partnerships #innovation #coloncancer #colorectalcancer #colonoscopy #colonoscope #lowergi #gastrointestinaltract #endoscopy #surgical #robotics #minimallyinvasive #surgery

Vivo Surgical is now a Johnson & Johnson Innovation - JLABS (Singapore) resident company! Consequently, we had the immense pleasure of being invited to San Diego, California, from 3 - 7 June 2024 as part of the JLABS Singapore Global Roadshow at the BIO International Convention. Besides thought provoking fireside chats and insightful investor meetings, we also had the opportunity to visit the JLABS Global HQ at Johnson & Johnson San Diego as well as participated in invaluable one-on-one discussions with JLABS leadership: Melinda Richter (Global Head), Sharon Chan (Asia Pacific Head) and Alessandro Falcone, MD (Singapore Regional Head). We look forward eagerly to the upcoming JLABS events for the year as well as to connecting with other company founders and CEOs in time to come. #JLABS #JLABSSingapore #VivoSurgical #VCJmatch #SingaporeEcosystem #BIO #SingaporeGlobalRoadshow #medtech #Innovation #opportunities #surgery #clinical #medicine #medicaltechnology #healthcare #medicaldevices #nasopharyngoscopy #enlyt #flexible #endoscopy #endoscope #gastrointestinalendoscopy #gi #colonoscopy #eres #endoscopicrobot #Innovation #roboticsurgery #surgicalrobotics #surgicalrobot #surgicalinnovation #esd #endoscopicsubmucosaldissection #surgeon #medical #operatingroom #operatingtheatre #surgicaltechnology